Trial of AAV-GAD gene remedy to be totally enrolled via finish of yr
A Section 1/2 medical trial trying out AAV-GAD, an investigational gene remedy being evolved via MeiraGTx for Parkinson’s illness, is predicted to be totally enrolled sooner than the tip of the yr,